Cargando…

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation

Detalles Bibliográficos
Autores principales:	He, Zifan, Li, Anlin, Lin, Dagui, Gu, Yang, Chen, Yongjian, Ou, Qiyun, Li, Liren, Yao, Herui, Yu, Yunfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591738/ https://www.ncbi.nlm.nih.gov/pubmed/33135355 http://dx.doi.org/10.1002/ctm2.214

Ejemplares similares

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
por: Yu, Yunfang, et al.
Publicado: (2020)

Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
por: Yu, Yunfang, et al.
Publicado: (2020)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma
por: Ou, Qiyun, et al.
Publicado: (2020)

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer: A Meta-analysis and Individual Patient–Level Analysis
por: Yu, Yunfang, et al.
Publicado: (2019)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021)

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
por: Ren, Wei, et al.
Publicado: (2022)

Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study
por: Liu, Jingwen, et al.
Publicado: (2022)

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma
por: Huang, Yunxi, et al.
Publicado: (2023)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases
por: Hendriks, Wiljan, et al.
Publicado: (2018)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Li, Chenchen, et al.
Publicado: (2022)

Identification of Phomoxanthone A and B as Protein Tyrosine Phosphatase Inhibitors
por: Yang, Runlei, et al.
Publicado: (2020)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
por: Yu, Yunfang, et al.
Publicado: (2023)

T Cell Protein Tyrosine Phosphatase in Osteoimmunology
por: Wang, Ya-nan, et al.
Publicado: (2021)

Eyes Absent Tyrosine Phosphatase Activity Is Not Required for Drosophila Development or Survival
por: Jin, Meng, et al.
Publicado: (2013)

Tyrosine phosphatase activity is restricted by basic charge substituting mutation of substrates
por: Huang, Che-Fan, et al.
Publicado: (2022)

Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
por: Chen, Chuan, et al.
Publicado: (2015)

The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib
por: Kumar, Ganesan Senthil, et al.
Publicado: (2020)

The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma
por: Huang, Yide, et al.
Publicado: (2018)

T Cell Protein Tyrosine Phosphatase in Glucose Metabolism
por: Wang, Ya-nan, et al.
Publicado: (2021)

New protein tyrosine phosphatase inhibitors from fungus Aspergillus gorakhpurensis F07ZB1707
por: Ji, Yannan, et al.
Publicado: (2021)

Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
por: Xie, Ning, et al.
Publicado: (2020)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
por: Yao, Yu, et al.
Publicado: (2023)

QSAR Study on a Series of Protein Tyrosine Phosphatase 1B Inhibitors
por: Mehta, Rajendra S., et al.
Publicado: (2008)

Protein Tyrosine Phosphatase 1B Inhibitors from the Stems of Akebia quinata
por: An, Jin-Pyo, et al.
Publicado: (2016)

Protein Tyrosine Phosphatase 1B Inhibitors from the Roots of Cudrania tricuspidata
por: Quang, Tran Hong, et al.
Publicado: (2015)

Asperentin B, a New Inhibitor of the Protein Tyrosine Phosphatase 1B
por: Wiese, Jutta, et al.
Publicado: (2017)

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors is the treatment option of previously treated advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
por: Yang, Xiaobo, et al.
Publicado: (2022)

Protein tyrosine phosphatases in glioma biology
por: Navis, Anna C., et al.
Publicado: (2009)

Metabolic regulation by protein tyrosine phosphatases
por: Knobler, Hilla, et al.
Publicado: (2014)

Role of Protein Tyrosine Phosphatases in Plants
por: Shankar, Alka, et al.
Publicado: (2015)

Crystal structure of the Yersinia tyrosine phosphatase
por: Bliska, James B.
Publicado: (1995)

Protein tyrosine phosphatases in cell adhesion
por: Young, Katherine A., et al.
Publicado: (2021)

Protein Tyrosine Phosphatases: Mechanisms in Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome
por: Courtet, Kevin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k5chkj39bnfp7vv196712fjqt6